相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b(+)/CD14(-)/CD15(+)/CD33(+) myeloid-derived suppressor cells and CD8(+) T lymphocytes in patients with advanced-stage non-small cell lung cancer
Chien-Ying Liu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Characterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear Cells
Melissa G. Lechner et al.
JOURNAL OF IMMUNOLOGY (2010)
Immunosuppressive CD14+HLA-DRlow/- Monocytes in Prostate Cancer
Stanimir Vuk-Pavlovic et al.
PROSTATE (2010)
Arginase I-Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
Paulo C. Rodriguez et al.
CANCER RESEARCH (2009)
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok et al.
CLINICAL CANCER RESEARCH (2009)
IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients
Susanna Mandruzzato et al.
JOURNAL OF IMMUNOLOGY (2009)
Lung cancer patients' CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells
Minu K. Srivastava et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Immunogenicity of the hTERT540-548 peptide in cancer
Lynn Wenandy et al.
CLINICAL CANCER RESEARCH (2008)
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells
Bastian Hoechst et al.
GASTROENTEROLOGY (2008)
Telomerase-specific T-Cell immunity in breast cancer: Effect of vaccination on tumor immunosurveillance
Susan M. Domchek et al.
CANCER RESEARCH (2007)
Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy
Mario P. Colombo et al.
NATURE REVIEWS CANCER (2007)
Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide
Irini Bolonaki et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Telomere and telomerase in stem cells
E. Hiyama et al.
BRITISH JOURNAL OF CANCER (2007)
A clinical development paradigm for cancer vaccines and related biologics
Axel Hoos et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
Paal F. Brunsvig et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX (R) vaccine in advanced-stage non-small-cell lung cancer
J Nemunaitis et al.
CANCER GENE THERAPY (2006)
A phase I study of the optimized cryptic peptide TERT572Y in patients with advanced malignancies
D. Mavroudis et al.
ONCOLOGY (2006)
Non-small-cell lung cancer vaccine therapy: A concise review
D O'Mahony et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients
GAH Danet-Desnoyers et al.
EXPERIMENTAL HEMATOLOGY (2005)
Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2005)
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy
DA Gross et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomerase
MR Parkhurst et al.
CLINICAL CANCER RESEARCH (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Prognostic factors in resected stage I non-small-cell lung cancer: A multivariate analysis of six molecular markers
C Lu et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen
C Lonchay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity
C Melani et al.
BLOOD (2003)
The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma
Y Fujita et al.
CANCER (2003)
Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas
TC Wu et al.
LUNG CANCER (2003)
End points and United States food and drug administration approval of oncology drugs
JR Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction
JC Schmollinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Epidermal growth factor-based cancer vaccine for non-small-cell lung cancer therapy
G Gonzalez et al.
ANNALS OF ONCOLOGY (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Tumor-specific shared antigenic peptides recognized by human T cells
P van der Bruggen et al.
IMMUNOLOGICAL REVIEWS (2002)
Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocyte's and mediates lysis of tumor cells
J Hernández et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy
A Scardino et al.
JOURNAL OF IMMUNOLOGY (2002)
Tumor-induced immune dysfunctions caused by myeloid suppressor cells
V Bronte et al.
JOURNAL OF IMMUNOTHERAPY (2001)
Avoiding tolerance against prostatic antigens with subdominant peptide epitopes
ME Grossmann et al.
JOURNAL OF IMMUNOTHERAPY (2001)
Clinical trial designs for the early clinical development of therapeutic cancer vaccines
RM Simon et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas
F Kumaki et al.
HUMAN PATHOLOGY (2001)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancer
R Pandit et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2000)
Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis
M Buyse et al.
LANCET (2000)
Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation
SA Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2000)
Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: Implications for tumor immunotherapy
TA Colella et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
SK Nair et al.
NATURE MEDICINE (2000)
分享论文
